There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PharmaTher Holdings Ltd (PHRRF – Research Report), Rezolute (RZLT – Research Report) and ADC Therapeutics (ADCT – Research Report) with bullish sentiments.
PharmaTher Holdings Ltd (PHRRF)
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on PharmaTher Holdings Ltd, with a price target of C$5.00. The company’s shares closed last Friday at $0.10, close to its 52-week low of $0.08.
According to TipRanks.com, Trucchio is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on PharmaTher Holdings Ltd is a Moderate Buy with an average price target of $3.77.
See today’s best-performing stocks on TipRanks >>
Rezolute (RZLT)
In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Rezolute, with a price target of $21.00. The company’s shares closed last Friday at $2.71, close to its 52-week low of $2.06.
According to TipRanks.com, Tsao is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Rezolute with a $14.25 average price target, which is a 422.0% upside from current levels. In a report issued on September 12, Jefferies also initiated coverage with a Buy rating on the stock with a $11.00 price target.
ADC Therapeutics (ADCT)
H.C. Wainwright analyst Robert Burns reiterated a Buy rating on ADC Therapeutics today and set a price target of $21.00. The company’s shares closed last Friday at $5.25, close to its 52-week low of $5.20.
According to TipRanks.com, Burns is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ADC Therapeutics with a $20.33 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PHRRF:
- Analysts Offer Insights on Technology Companies: Rigetti Computing (RGTI) and JFrog (FROG)
- Blubird bio (NASDAQ:BLUE) Rises on Gene Therapy Approval
- H.C. Wainwright Sticks to Their Buy Rating for Ayala Pharmaceuticals (AYLA)
- H.C. Wainwright Remains a Buy on Tyra Bioscience (TYRA)
- H.C. Wainwright Keeps Their Buy Rating on Enlivex Therapeutics (ENLV)
